Kevin Norrett - Mar 14, 2022 Form 4 Insider Report for Sierra Oncology, Inc. (SRRA)

Role
Chief Business Officer
Signature
/s/ Mary Christina Thomson, Attorney-In-Fact for Kevin Norrett
Stock symbol
SRRA
Transactions as of
Mar 14, 2022
Transactions value $
$0
Form type
4
Date filed
3/14/2022, 04:43 PM
Previous filing
Jan 28, 2022
Next filing
Jun 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRRA Stock Option (Right to Buy) Award $0 +35K $0.00 35K Mar 14, 2022 Common Stock 35K $31.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the total shares subject to the option on March 14, 2023, and then 2.0833% of the shares subject to the option vest monthly thereafter, with 100% of the total shares subject to the option vested on March 14, 2026, subject to Reporting Person's provision of service to the Issuer on each vesting date.